logo
AI Icon𝛼SK or Search
ENTITY

Immix Biopharma Inc (IMMX US)

43
Analysis
Health Care • United States
Immix Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel class of tissue-specific therapeutics in oncology and inflammation to treat inflammatory bowel disease, including ulcerative colitis and crohn's diseases. Immix Biopharma serves customers in the United States.
more
Company Event • 11 Nov 2026 05:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 07 Oct 2026 20:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 29 Sep 2026 20:00 • Latest

Study result

Company Event • 15 Sep 2026 04:50

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 01 Sep 2026 20:00 • Upcoming
Add To Calendar

Corporate presentation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x